The near future is looking bleak for publicly traded home care companies. The first of the"big four" to report its earnings following the Senate's damning therapy report, Amedisys Inc. disclosed a whopping $423.7 million loss on $374.9 million in revenues for the quarter ended Sept. 30. That compares to a $21.8 million profit on $404.7 million in revenues for the same period in 2010. The loss was due in part to a big $574 million write-down the company took after conducting an impairment test. "This was a difficult quarter for the company," CEO William Borne says in the earnings release. Heads roll: Key top execs are departing, Amedisys also has announced. COO Mike Snow is leaving and CFO Dale Redman will retire in early 2012. And the Baton Rouge, La.,-based chain plans to close or sell 50 locations. "Amedisys' management shake-up, its weak operating and financial trajectory, and the highly uncertain home nursing reimbursement environment combine for a stormy near-term outlook," says Arthur Henderson, an analyst with Jefferies & Co. in Nashville, Tenn., according to Bloomberg Business Week. Stock prices for all of the "big four" home care chains fell on the news.